March 2026 Issue is Now Live!

Features

Controlled Substance for Medical Device Materials

AI-driven modeling, device miniaturization, and personalized implants are driving medtech materials science innovation.

SPONSOR

Critical Considerations in Selecting a Manufacturing Partner—A Medtech Makers Q&A

Medical device organizations should be seeking a company they can view as an extension of their own internal capabilities.

Features

Medical Device Testing in Transition

New demands, regulations, and concerns have testing organizations doing more to ensure the safety and compliance of new devices.

Features

Staying in Target Range with Diabetes Technologies

Continuous glucose monitors, smart insulin pumps, and integrated digital health tools are transforming diabetes management.

Industry Voices

Touching a Nerve: An Interview with LivaNova CEO Vladimir Makatsaria

Neuromodulation technologies offer hope for patients with specific conditions that cannot be suitably treated with pharmaceutical options.

Editor's Letter

Dropping the Hammer on Tariffs (…or Continued Tariff Uncertainty)

The U.S. Supreme Court recently ruled against President Trump’s use of tariffs through a series of executive orders.

Dollars & $ense

Why Most Medtech Value Is Created After Launch and Founders Underestimate the Gap

Many teams assume valuation peaks at regulatory approval. It rarely works that way.

Design Viewpoint

Cybersecurity in Medical Devices: Enhancing SBOM & Threat Controls with Iterative Development

How agile methods can help companies effectively manage evolving cybersecurity and SBOM (software bill of materials) challenges.

Supply Chain

From Reactive to Proactive: Planning Strategies for Medtech Customer and Margin Success

Forward-thinking, predictive planning strategies will be integral to thriving in the new global environment. 

Cybersecurity

FDA’s Top 10 Cybersecurity Reasons for a Hold Letter

A list of the details FDA has disclosed for the last two years (the list hasn’t changed) of the most frequent errors made in cybersecurity during a submission.

C-Suite Reflections

Tariffs and the Medtech Industry: Disruption, Realignment, and Strategic Consequences 

C-suites are being forced to include tariff dynamics into their short-term and long-term strategies.

Regulatory Perspectives

Meeting the New Standard for Safety Data Quality

Manufacturers must evolve from retrospective data collection to a more proactive, intelligence-driven approach.

Talent Matters

Building Workforce Trust and Security During Disruptive Times

Employers engender trust in their people when they demonstrate authentic engagement efforts.

From the Bench

Countdown to the QMSR Ball Drop

Manufacturers must recognize that compliance to ISO 13485 alone does not equate to compliance to the QMSR.

Datawatch

Electrophysiologists’ Priorities for Medtech in 2026

What's essential for successful electrophysiology product adoption and shaping R&D, market access, and commercialization strategy.

Medtech Musings

An Inside Look at the Alcon-STAAR Surgical Deal Collapse

Alcon and STAAR Surgical Company announced their impending—though doomed—union last summer.

Solution Content Centers SPOTLIGHT

Providence Enterprise USA Inc.

Providence Enterprise is a medical device contract manufacturer of Class I, II, and III medical devices with manufacturing in China, Vietnam, and Mexico. We specialize in electro-mechanical assemblies and high volume disposables. We are FDA registered and ISO 13485, ISO 14971, ISO 14001, ISO 27001 certified. Our capabilities include industrial design, design for manufacturing, fabricating tooling for silicone rubber and injection molded plastics, clean room injection molding, electronics, clean room assembly, and sterilization.